NHS Approves First HIV Prevention Jab in England and Wales

Published 12 hours ago·Updated 11 hours ago

story

Image copyright: Unsplash

The Spin

Pro-government narrative

The NHS breakthrough approval of cabotegravir injections is a game-changing milestone toward ending HIV transmissions by 2030. This innovative long-acting prevention tool will reach vulnerable populations facing barriers to daily medication, providing life-changing access for those with unstable housing or stigma concerns. England is pioneering global leadership in HIV elimination through cutting-edge treatments that save lives and advance equity in public health.

NHS England Local Government Association

National AIDS Trust on X

Government-critical narrative

NHS England's drug approval system remains fundamentally broken, leaving patients without access to life-saving treatments due to bureaucratic failures and pricing disputes. The closure of lenacapavir's compassionate access program after two years of stalled negotiations shows how the system abandons people with limited treatment options. Less than 5% of individual funding requests get approved, creating deadly barriers to essential medications.

HIV i-BASE

Laura Waters on LinkedIn